Altimmune's Fatty Liver Candidate Faces Differentiation Doubts - Altimmune ( NASDAQ:ALT )
Trucchio maintains Buy rating, sees $12 upside on positive 48-week fibrosis readout. William Blair flags underwhelming 24-week data, sees limited 48-week improvement potential. Geopolitical tensions, Fed uncertainty, and fast-moving headlines are driving July volatility.
Nvidia Is Acquiring Its Way Into AI - NVIDIA ( NASDAQ:NVDA )
Nvidia acquires Canadian AI startup CentML to boost efficiency and performance in AI software CentML team, including CEO Pekhimenko, joins Nvidia as the startup shuts down operations in July Market-moving news hits Benzinga Pro first-get a 30-minute edge and save 60% this 4th of July.
BTC Miner Offers Passive Income Platform with Million-Dollar Potential
New York City, June 27, 2025 ( GLOBE NEWSWIRE ) -- BTC Miner, a leading global cloud mining platform, officially launches a new high-yield cloud mining contract, providing digital asset holders with a passive income channel that requires no trading and is immune to market fluctuations, with ...
Theranos Makes a Big Bang at the FDA
PALM BEACH, Fla., June 27, 2025 ( GLOBE NEWSWIRE ) -- Today marks a significant milestone for theranos and its diagnostic technology. The theranos system performs automated sample processing and analysis to produce clinical test results. The U.S.
Banco Comercial Português, S.A. informs about Interim report on the transactions conducted under the Share Buy- Back Programme
Banco Comercial Português, S.A. informs about Interim report on the transactions conducted under the Share Buy- Back Programme © 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Molson Coors Hurt By Fewer People Drinking Beer, Warns Analyst - Molson Coors Beverage ( NYSE:TAP )
Analyst cuts TAP price forecast to $50, citing continued volume declines. The analyst cut their FY25 and FY26 EPS estimates for Molson Coors Beverage from $6.02/$6.55 to $5.70/$6.02. Get ahead of Wall Street reactions-Benzinga Pro delivers signals, squawk, and news fast.
Strength Seen in Enovix Corporation ( ENVX ) : Can Its 20.8% Jump Turn into More Strength?
Enovix Corporation (ENVX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Stem ( STEM ) Soars 8.8%: Is Further Upside Left in the Stock?
Stem (STEM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Should You Consider Ralph Lauren Stock Despite Its Elevated Valuation?
RL's brand strength, digital expansion and global momentum drive investor confidence despite macro headwinds.
Upstart Stock Appreciates 40% QTD: Should You Take the Bait?
UPST surges 40% this quarter, driven by AI-fueled lending gains - does its growth justify the lofty valuation?
